
Iran and its Lebanese Hezbollah militia proxy on Thursday fired rockets again at Israel, where people are currently celebrating Passover.
In the morning, warning sirens sounded repeatedly in northern Israel. Two men were slightly injured by a Hezbollah rocket, the Magen David Adom emergency service said.
An Iranian rocket also aimed at the north was fitted with cluster munitions, Israeli media reported. The use of cluster munitions is widely banned internationally because they can scatter explosive devices uncontrollably over large areas and are particularly dangerous for civilians.
There was also repeated fire at Israel overnight. A rocket alert was triggered in the coastal metropolis of Tel Aviv, among other places. Magen David Adom reported several people with minor injuries from broken glass in a suburb of Tel Aviv, including two babies.
The week-long Passover festival began on Wednesday evening for Jews around the world. It commemorates the exodus of the Israelites from Egypt and their liberation from slavery.
LATEST POSTS
- 1
Dwayne ‘the Rock’ Johnson opens up about being the 'new guy' again — and why this moment feels like a new life - 2
NASA Artemis II tracker: Where is the Orion now and when will it reach the moon? - 3
Cocoa Prices Settle Lower on Expectations of Adequate Supplies - 4
6 Novice Cameras for 2024: Ideal for New Picture takers - 5
Iran Used $2 Billion in Crypto to Run Its Militant Proxies in 2025
German Cabinet advances bill to cut greenhouse emissions from fuels
Mobility exercises are an important part of fitness as we age. Here are some tips
Green Inflections: A Manual for Inside Plants
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
Manual for Tracking down the Mysterious Cascades in China
Gulf of Mexico oil spill spread hundreds of miles, killed wildlife and polluted Mexican reserves
Instructions to Pick the Right Tires for Your Slam 1500.
Sought-After Extravagance Ocean side Objections for a Lovely Escape
Impact of NIH funding reductions felt in cancer and infectious disease trials













